A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.

scientific article published on January 2014

A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4088/JCP.13M08411
P698PubMed publication ID24345329

P50authorMarc N. PotenzaQ25336883
Samuel R. ChamberlainQ37828940
Brian L. OdlaugQ40772435
Jon E GrantQ91080825
Suck Won KimQ117281750
Liana R N SchreiberQ117281751
P2093author name stringChristopher B Donahue
P433issue1
P921main subjectplaceboQ269829
acetylcysteineQ375613
desensitizationQ2700499
placebo-controlled trialQ108853737
P304page(s)39-45
P577publication date2014-01-01
P1433published inThe Journal of Clinical PsychiatryQ7743563
P1476titleA randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers
P478volume75

Reverse relations

cites work (P2860)
Q37580733A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders
Q47615470An Analysis of Treatment-Seeking Behavior in Individuals with Gambling Disorder
Q30383838Behavioral addictions in addiction medicine: from mechanisms to practical considerations.
Q47116378Clinical neuropsychiatric considerations regarding nonsubstance or behavioral addictions
Q64913181Correlates of frequent gambling and gambling-related chasing behaviors in individuals with schizophrenia-spectrum disorders.
Q47339973Effect of N-acetylcysteine on motivation, seeking and relapse to ethanol self-administration.
Q64112212Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions
Q92186073Gambling disorder
Q35690154Gambling disorder and other behavioral addictions: recognition and treatment
Q43076075Glial and neuroinflammatory targets for treating substance use disorders
Q38729846Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse
Q28081726Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
Q57602440Manifesto for a European research network into Problematic Usage of the Internet
Q34543171N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
Q55032013N-acetylcysteine: A potential treatment for substance use disorders.
Q64910100Pharmacological Treatments for Disordered Gambling: A Meta-analysis.
Q33821312Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.
Q37062547The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
Q38831858The current clinical knowledge on the treatment of gambling disorder: A summary
Q33955187The neural bases of cognitive processes in gambling disorder
Q41211388The placebo effect and its clinical associations in gambling disorder
Q33617805Treatment modalities for patients with gambling disorder
Q33698391Treatment of Gambling Disorders

Search more.